<DOC>
	<DOCNO>NCT02947061</DOCNO>
	<brief_summary>To compare progression free survival ( PFS ) safety TS-S vs. TX-X Patients With Advanced Breast Cancer first-line treatment</brief_summary>
	<brief_title>S1 Plus Docetaxel Versus Capecitabine Plus Docetaxel First-line Treatment Patients With Advanced Breast Cancer</brief_title>
	<detailed_description>To compare progression free survival ( PFS ) S-1 combine docetaxel follow maintenance treatment S-1 capecitabine combine docetaxel follow maintenance therapy capecitabine patient advance breast cancer first-line treatment .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<criteria>18 ≤ age ≤ 75 ; ECOG 02 , The expect survival time 3 month ; Histologically cytologically proven locally advanced advanced HER2 negative breast cancer ; No chemical treatment Cancer recurrence ; At least one measurable disease ( per RECIST1.1 ) ; Adequate bone marrow function ( ANC ≥1.5×109 /L , PLT ≥100×109 /L , HB ≥90 g/L ) ; Adequate renal function ( serum creatinine ≤ 1.5 ULN ; creatinine clearance≥50 ml/min ) ; liver function ( serum bilirubin ≤ 1.5ULN , AST/ALT ≤ 2.5 ULN ) ; Written inform consent ; Pregnancy test ( serum urine ) within 7 day entry willing use appropriate method contraception . Previously chemotherapy cytotoxic drug Pregnant , lactate woman Did take effective contraceptive measure Adjuvant chemotherapy/ neoadjuvant chemotherapy 5FUbased chemotherapy Paclitaxel base chemotherapy within 1 year recurrence ; Her2 positive unknown Other trail Before 4weeks Affection absorption drug ( Unable swallow、after gastrectomy、Chronic diarrhea intestinal obstruction Organs rapid progression invasion ( Liver lung lesion 1/2 organ area hepatic insufficiency ) Central nervous system disorder mental disorder For docetaxel fluorouracil Twain 80 serious adverse reaction Allergy 5FU Severe upper gastrointestinal ulcer absorption dysfunction syndrome Abnormal blood routine ( ANC &lt; 1.5×109 /L , PLT &lt; 100×109 /L , HB &lt; 90 g/L ) ; Renal function ( serum creatinine &gt; 1.5 ULN ) ; Liver function ( serum bilirubin &gt; 1.5ULN Brain metastasis control Other unapplicable</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Advanced Breast Cancer , first treatment , S1 , Capecitabine</keyword>
</DOC>